Skip to content

Compliance Objectively measured in a Multicultural Population of children Living In Amsterdam Needing inhaled Corticosteroids for Effective asthma treatment.

Compliance Objectively measured in a Multicultural Population of children Living In Amsterdam Needing inhaled Corticosteroids for Effective asthma treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29533
Enrollment
225
Registered
2008-07-11
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

compliance, inhaled corticosteroids, ethnicity, children, therapietrouw, inhalatiecorticosteroiden, etniciteit, kinderen

Interventions

None (observational study approach)

Sponsors

drs Vasbinder EC, dr Wolf B, drs Dahhan N, dr Bemt PMLA van den Sint Lucas Andreas Ziekenhuis, Jan Tooropstraat 164, 1061 AE, Amsterdam, 0205108590, e.vasbinder@slaz.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient is attending the pediatric outpatient department of the St Lucas Andreas Hospital in Amsterdam, AMC or BovenIJ. 2. ICS use during at least the preceding 6 months using a pMDI. 3. Age of max. 11 years old. 4. Dutch, Turkish or Moroccan ethnicity

Exclusion criteria

Exclusion criteria: 1. Refusal to participate 2. Incapability of understanding the RTMEMS instructions. (this exclusion criterium only counts for the electronic measurements)

Design outcomes

Primary

MeasureTime frame
The proportion of noncompliant administrations of the total number of administrations.

Secondary

MeasureTime frame
- The MARS questionnaire data, compared to the RTMEMS as a gold standard. - The association of determinants with non-compliance.

Contacts

Public ContactE.C. Vasbinder

Erasmus MC Afdeling apotheek Cluster 7 Postbus 2040

erwinvasbinder@gmail.com+31 (0)10 7033202

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)